Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.92 USD | -8.72% | -7.34% | +8.85% |
05-09 | Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M | MT |
05-09 | Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 54.79M 74.96M | Sales 2025 * | 138M 189M | Capitalization | 88.78M 121M |
---|---|---|---|---|---|
Net income 2024 * | -14M -19.16M | Net income 2025 * | 11M 15.05M | EV / Sales 2024 * | 1.62 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.64 x |
P/E ratio 2024 * |
-5.96
x | P/E ratio 2025 * |
10.3
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.03% |
Latest transcript on ProPhase Labs, Inc.
1 day | -8.72% | ||
1 week | -7.34% | ||
Current month | +6.72% | ||
1 month | -19.34% | ||
3 months | -6.11% | ||
6 months | -3.53% | ||
Current year | +8.85% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Chief Operating Officer | 50 | 12-31 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 09-05-31 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Jason Barr
BRD | Director/Board Member | 44 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 0 M€ | -2.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 4.92 | -8.72% | 71,137 |
24-05-08 | 5.39 | +6.52% | 57,288 |
24-05-07 | 5.06 | -5.24% | 15,936 |
24-05-06 | 5.34 | -1.48% | 40,416 |
24-05-03 | 5.42 | +2.07% | 38,408 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.85% | 88.78M | |
-16.74% | 8.44B | |
+54.07% | 3.96B | |
-37.54% | 2.52B | |
-9.63% | 2.44B | |
-12.13% | 2.22B | |
-4.20% | 1.98B | |
-18.24% | 1.58B | |
-36.41% | 1.3B | |
+2.19% | 1.05B |
- Stock Market
- Equities
- PRPH Stock